Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

联系我们

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

隐私政策

政策

Search research articles

选择性环氧化原酶-2 抑制剂在心血管医学中的发展.

Domenico Praticò¹, Jean-Michel Dogné

¹Department of Pharmacology, University of Pennsylvania, School of Medicine, Philadelphia, USA. domenico@spirit.gcrc.upenn.edu

Circulation

|August 17, 2005

概括

No abstract available in PubMed .

相关实验视频

选择性环氧化原酶-2 抑制剂在心血管医学中的发展.

相关概念视频

Temporal and Regional Circular RNA profiling in a Tauopathy Mouse Model: Implications for Tau Pathology and Neurodegeneration.

Adherence to Mediterranean diet: a public health paradox.

Necroptosis in Down Syndrome.

Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil Model.

Modeling and Simulation in Development and Regulatory Approval of Chimeric Antigen Receptor T-Cell Therapies: An Analysis of European Medicines Agency Centralized Procedures From 2018 to 2024.

Use of Modeling and Simulation to Inform the Development of Monoclonal Antibodies to Treat Moderate-to-Severe Asthma: A Retrospective Review of EMA Centralized Procedure From 2014 to 2024.

相关实验视频

选择性环氧化原酶-2 抑制剂在心血管医学中的发展.

相关概念视频

相关文章

Temporal and Regional Circular RNA profiling in a Tauopathy Mouse Model: Implications for Tau Pathology and Neurodegeneration.

Adherence to Mediterranean diet: a public health paradox.

Necroptosis in Down Syndrome.

Evaluation of NETosis Inhibitors in a Laboratory-Developed ex-vivo Human Neutrophil Model.

Modeling and Simulation in Development and Regulatory Approval of Chimeric Antigen Receptor T-Cell Therapies: An Analysis of European Medicines Agency Centralized Procedures From 2018 to 2024.

Use of Modeling and Simulation to Inform the Development of Monoclonal Antibodies to Treat Moderate-to-Severe Asthma: A Retrospective Review of EMA Centralized Procedure From 2014 to 2024.